Linz, Austria

Cl Pharma Aktiengesellschaft


USPTO Granted Patents = 11

Forward Citations = 24

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Dieter Binder (3 out of 35 patents)

silverMedal Hubert P Ferber (3 out of 9 patents)

bronzeMedal Karl Schermanz (3 out of 6 patents)

4.  Gerald Saischek (3 out of 6 patents)

5.  Kurt Martetschlager (3 out of 4 patents)

6.  Robert Urmann (2 out of 2 patents)

7.  Franz Rovenszky (2 out of 11 patents)

8.  Karl Baumann (1 out of 5 patents)

9.  Albin Hermetter (1 out of 11 patents)

10.  Harald Fellier (1 out of 3 patents)

11.  Heinz Blaschke (1 out of 3 patents)

12.  Dietmar Kores (1 out of 4 patents)

13.  Josef Graf (1 out of 2 patents)

14.  Gerhard Haas (1 out of 2 patents)

15.  Franz Rovensky (1 out of 2 patents)


11 patents:

Company Overview
Cl Pharma Aktiengesellschaft is a biotechnology company based in Linz, Austria, specializing in the development and manufacturing of innovative pharmaceutical products. The organization focuses on research in the fields of drug formulation and delivery systems, aiming to enhance therapeutic efficacy and patient compliance. With a commitment to advancing healthcare solutions, Cl Pharma engages in collaborative projects that leverage cutting-edge technologies to address unmet medical needs in various therapeutic areas.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#18 in Linz

#287 in Austria

#51,714 in the World

Linz, AT
Linz, Austria
Forward Citations = 24

21 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cl Pharma Aktiengesellschaft. Retrieved from https://idiyas.com/company/cl-pharma-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…